Syberka-Clinhouse Sp. z o.o.
- Address
- Ul. Zwyciestwa 30, 42-500 Będzin, Poland
Bacterial Infections and Mycoses
At Syberka-Clinhouse Sp. z o.o. in Bedzin, research in this area focuses on bacterial infections, especially bacterial vaginosis. The studies are designed to assess whether a new local treatment can match the effectiveness of an established therapy while supporting better options for women’s health.
- Evaluation of a new vaginal treatment for bacterial vaginosis
- Comparison with an established antibiotic therapy
- Research aimed at improving treatment effectiveness for infectious diseases
This work reflects a focused effort in infectious disease care, with attention to practical treatment choices that may improve patient outcomes.
Nervous System Diseases
The site is also active in nervous system diseases, with trials centered on Early Symptomatic Alzheimer’s Disease and related stages from MCI to mild dementia. These studies are exploring whether a new therapy can slow clinical progression and support better management of Alzheimer’s disease.
- Testing a potential treatment for Early Symptomatic Alzheimer’s Disease
- Assessing impact on clinical progression over time
- Supporting research into earlier intervention for Alzheimer’s disease
With this research, Syberka-Clinhouse Sp. z o.o. contributes to efforts aimed at improving care for people in the early stages of neurodegenerative disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Adamed Pharma S.A.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1F. Hoffmann-La Roche AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Syberka-Clinhouse Sp. z o.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase III, randomized, open label, non-inferiority study comparing the efficacy and safety of furazidin vaginal tablets and clindamycin vaginal cream in the local treatment of bacterial vaginosis | Adamed Pharma S.A. | Phase III | Recruiting | Feb 2026 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Florbetaben (18F) | 2 | Unknown | 2025-11-12 | 2025-11-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.